trial · primary record
Codrituzumab
Primary Extra-cranial Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2027-06 |
| Primary endpoint | estimate the MTD |
| Registry ID | NCT04928677 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:39.436Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04928677
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.